18264314. METHODS AND BIOMARKERS IN CANCER simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
Contents
- 1 METHODS AND BIOMARKERS IN CANCER
- 1.1 Organization Name
- 1.2 Inventor(s)
- 1.3 METHODS AND BIOMARKERS IN CANCER - A simplified explanation of the abstract
- 1.4 Simplified Explanation
- 1.5 Potential Applications
- 1.6 Problems Solved
- 1.7 Benefits
- 1.8 Potential Commercial Applications
- 1.9 Possible Prior Art
- 1.10 Unanswered Questions
- 1.11 Original Abstract Submitted
METHODS AND BIOMARKERS IN CANCER
Organization Name
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor(s)
Scott M. Lippman of La Jolla CA (US)
Webster K. Cavenee of La Jolla CA (US)
Teresa Davoli of New York NY (US)
METHODS AND BIOMARKERS IN CANCER - A simplified explanation of the abstract
This abstract first appeared for US patent application 18264314 titled 'METHODS AND BIOMARKERS IN CANCER
Simplified Explanation
The patent application abstract describes methods for diagnosing, prognosticating, and treating based on identifying a specific genotype.
- Diagnostic, prognostic, and therapeutic methods are provided based on determining the genotype of interest.
- The innovation involves utilizing genotype information for medical purposes.
Potential Applications
The technology could be applied in personalized medicine, genetic testing, and targeted therapies.
Problems Solved
This technology helps in identifying specific genotypes for more accurate diagnosis and treatment.
Benefits
The benefits include more precise medical interventions, improved patient outcomes, and personalized healthcare.
Potential Commercial Applications
The technology could be used in healthcare settings, pharmaceutical companies, and genetic testing laboratories.
Possible Prior Art
Previous methods of genetic testing and personalized medicine may be considered as prior art.
Unanswered Questions
How does this technology compare to existing diagnostic methods?
Answer: The article does not provide a direct comparison with current diagnostic techniques.
What are the potential limitations of using genotype information for medical purposes?
Answer: The article does not address any potential drawbacks or limitations of utilizing genotype information in healthcare.
Original Abstract Submitted
The disclosure further provides diagnostic, prognostic and therapeutic methods, which are based, at least in part, on determination of the identity of a genotype of interest identified herein.
